Integra LifeSciences to Present at the 2023 Wells Fargo Healthcare Conference
September 01 2023 - 5:04PM
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading
global medical technology company, announced today that Lea Knight,
chief financial officer will present at the 2023 Wells Fargo
Healthcare Conference on September 6, 2023 at 1:30 p.m. EST.
A live webcast of the presentation will be
available on the Integra LifeSciences investor relations website at
http://investor.integralife.com/events-and-presentations.
About Integra LifeSciencesAt Integra
LifeSciences, we are driven by our purpose of restoring patients’
lives. We innovate treatment pathways to advance patient outcomes
and set new standards of surgical, neurologic and regenerative
care. We offer a comprehensive portfolio of high quality,
leadership brands that include AmnioExcel®, Aurora®, Bactiseal®,
BioD™, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®,
DuraGen®, DuraSeal®, DuraSorb®, Gentrix®, ICP Express®, Integra®,
Licox®, MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®,
NeuraGen®, NeuraWrap™, PriMatrix®, SurgiMend®, TCC-EZ® and
VersaTru®. For the latest news and information about Integra and
its products, please visit www.integralife.com.
Investor Relations:Chris
Ward(609) 772-7736chris.ward@integralife.com
Media Contact:Laurene
Isip(609) 208-8121laurene.isip@integralife.com
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From Apr 2024 to May 2024
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From May 2023 to May 2024